Kamada Ltd (KMDA)
Kamada Ltd (KMDA) is an Israel-based biopharmaceutical company specializing in the development, manufacturing, and commercialization of plasma-derived protein therapeutics for the treatment of various medical conditions, such as rare diseases and inflammatory disorders. The company's products are based on plasma proteins, including Alpha-1 antitrypsin, used for treatment and research purposes. Kamada leverages its proprietary manufacturing platform to produce plasma-derived therapies and expand its portfolio in the biopharmaceutical space.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| April 7, 2025 | $0.20 | 2025-03-17 | 2025-03-17 |
Dividends Summary
- Kamada Ltd has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 200 days ago, on April 7, 2025
- The highest dividend payed out to investors during this period was $0.20 per share
- The average dividend paid during this period was $0.20 per share.
Company News
Kamada Ltd., a global biopharmaceutical company, announced that it will release its financial results for the fourth quarter and fiscal year ended December 31, 2024, on March 5, 2025. The company will host an investor conference call to discuss the results.
Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near people using ParaZero safety systems. HUB Cyber Security Ltd. (NASDAQ: HUBC) shares jumped 60.5% to $0.3836. Phoenix Motor Inc. (NASDAQ: PEV) climb...
Shares of Israeli pharmaceutical giant Teva are down Monday following Hamas's attack over the weekend.
Zymeworks (ZYME) recently entered a collaboration with Jazz Pharmaceuticals (JAZZ) for its lead pipeline candidate. This has been a significant catalyst for the stock.